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Abstract
The COVID-19 pandemic quickly led to an abundance of publications and recommen-
dations, despite a paucity of information on how COVID-19 affects children with can-
cer. This created a dire need for a trusted resource with curated information and a
space for the pediatric oncology community to share experiences. The Global COVID-
19 Observatory and Resource Center for Childhood Cancer was developed, launched,
and maintained by the International Society of Pediatric Oncology and St. Jude Chil-
dren’s Research Hospital. The three components (Resource Library, Global Registry,
and Collaboration Space) complement each other, establishing a mechanism to gener-
ate and transfer knowledge rapidly throughout the community.
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After rapidly spreading across the globe, COVID-19 officially became a
pandemic on March 11, 2020.1 Initial reports suggested that patients
with comorbidities were at higher risk, causing concern that children
with cancer were at risk of developing severe infection.2 Furthermore,
measures to mitigate the spread of the virus, such as delaying medical
procedures and travel restrictions, were anticipated to disturb the con-
tinuity of pediatric cancer care.3 It was also anticipated that the effects
of the pandemic on health systems would amplify existing obstacles to
caring for children with cancer.3
Since thebeginning of thepandemic, a delugeof information regard-
ing disease characteristics and possible management strategies was
disseminated. This infodemic, an overabundance of information during
an epidemic,4 has posed challenges never encountered before andwas
an early concern.5 The rapid spread of information and misinforma-
tion, potentiated by social media platforms, presented a public health
challenge, confusing and overwhelming healthcare professionals and
lay public alike.
In response to the need for a trusted resource with curated, reli-
able information and a platform to share experiences for the pediatric
oncology community, the International Society of Pediatric Oncology
(SIOP) and St. Jude Children’s Research Hospital (SJCRH) created the
Global COVID-19 Observatory and Resource Center for Childhood
Cancer (GCORCCC). The GCORCCC was launched as an open-access
website (covid19childhoodcancer.org) on April 15, 2020.
2 GENERAL OVERVIEW OF THE RESOURCE
CENTER
The GCORCCC comprises three main elements: Resource Library,
Global Registry, and Collaboration Space, outlined below. As of Octo-
ber 20, 2020, the GCORCCC has 64,980 page views by 32,295 unique
users from 164 countries (Figure 1). Additionally, to address questions
related to pediatric cancer care during the pandemic in a live and inter-
activeway, a series ofwebinars entitledCOVIDConversationshavebeen
hosted. To date, 11 sessions directed at various aspects of cancer care
and disciplines, including pediatric oncologists, nurses, surgeons, radi-
ation oncologists, nongovernmental organizations, parents, and sur-
vivors, have been held. Regionally focused sessions were also held for
Northern Italy and Spain, India and Pakistan, Latin America, and Africa.
On average, the webinars have been attended by 337 people from
70 countries.
2.1 Resource library
The Resource Library contains updated curated peer-reviewed
manuscripts, guidance documents, and links relevant to the multidisci-
plinary care of children with cancer during COVID-19.6 Publications
are reviewed and assessed for relevance weekly for inclusion.7 We
prioritize the dissemination of accurate data and quickly identify
and address misinformation or conflicting reports. Only peer-
reviewed articles are included, as unvetted scientific information,
such as preprints, were identified as a risk for misinformation for
providers.8-10
The sections of the Resource Library are as follows: COVID-19
and Pediatric Oncology, General COVID-19 Information, Treatment,
Prevention, For Healthcare Providers, and For Patients and Families.
Each sectionprovides a collectionof publications, guidancedocuments,
recordedwebinars, and relevant links.
To address the needs of healthcare professionals during this
unprecedented time, resources focusing on leadership, self-care, and
resiliency are also included in the Resource Library. Additionally, a sub-
section specifically aimed at nurses, with literature and guidance docu-
ments, was developed. The Pediatric Oncology Nursing during COVID-19
Fact Sheet summarizes the most relevant guidance for caring for chil-
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F IGURE 1 Global COVID-19Observatory and Resource Center for Childhood Cancer usage
Individuals frommore than 160 countries from across the world accessed the GORCCC
dren with cancer and is available in six languages as a quick bedside
reference. Finally, a section with resources for patients and families
aids bedside providers in educating and navigating patients and fami-
lies toward trusted, accurate sources of information.
2.2 Registry
At the beginning of the pandemic, the natural history of COVID-19 in
childrenandadolescentswith cancerwasunknown.Togain anaccurate
picture of the burden of COVID-19 among this patient population, we
developed theGlobal COVID-19Registry. Healthcare providersworld-
wide were invited to voluntarily report any patient (under 19 years of
age) with amalignancy or history of hematopoietic stem cell transplant
at the time of a laboratory-confirmed SARS-CoV-2 infection. The Reg-
istry was approved by the SJCRH Institutional Review Board.
As of December21, 2020, 1228 cases from 46 countries have been
reported. Using aggregate data, we created an interactive data visual-
ization dashboard to provide updates in a dynamic format (Figure 2).
The data visualization allows providers to filter cases by variables such
as underlying diagnosis, cancer treatment, and COVID-19 outcomes.
2.3 Collaboration space
Creating an opportunity to bring the global community of healthcare
professionals together is an essential component of the GCORCCC.
The Collaboration Space provides a forum for healthcare professionals
to interact and share their experiences and questions about caring for
children with cancer during the COVID-19 pandemic. The Collabora-
tion Space has language translation capabilities, making it accessible to
a large number of providers globally. Here, users are also able to access
content, such as videos, blog posts, and live events.
Through sharing experiences, providers can support and learn from
each other. From the Frontlines is a blog series published to highlight
unique accounts of childhood cancer providers navigating COVID-19
around the world. To date, the blog features stories from 24 providers
in 19 countries. These providers discuss the challenges their teams
have faced and innovative solutions they have employed to continue
to treat childrenwith cancer during the pandemic. Currently, there are
1300 total active users registered in the Collaboration Spacewho have
connected and interacted over 36,000 times with content elements.
3 DISCUSSION
A rapidly evolving pandemic poses many challenges in caring for chil-
drenwith cancer. TheGCORCCCestablished amechanism to generate
and transfer knowledge for the pediatric oncology community during
a global pandemic and infodemic. Through its various elements, users
can access relevant information to help them adapt and respond to the
rapidly shifting situation.
Academic institutions and professional societies should play central
roles in the accurate and timely dissemination of information. For pro-
fessionals caring for children with cancer, the sharing of experiences
from regions that were affected early in the pandemic was essential
for formulating the initial responses to the evolving pandemic.11–13In
addition, guidance for the management of COVID-19 for different
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F IGURE 2 Screenshot of the visualization dashboard of the Global COVID-19 Registry
An interactive visualizationwas created to illustrate cases included in the Registry. Patients from 46 countries have been submitted (size of circle is
proportional to patient number)
patient populations was generated by government agencies and
professional societies with remarkable speed.14–16Importantly,
information sufficiency has been linked to less stress and worry
amongst health care professionals.17 For this reason, a resource
like the GCORCCC can support individuals to decrease burn out
and improve resilience. This effort brought colleagues together
and facilitated a sense of community in these trying times, in
an innovative approach to addressing global challenges in pedi-
atric cancer care. Many organizations attempted to compile
listing of resources that are relevant to their specific popula-
tions, but few of them also sought to create knowledge about
COVID-19 in their populations to add to the evidence-based
literature.
4 CONCLUSION
At a time of exceptionally high stakes for children with cancer, the
multi-stakeholder collaboration that led to the GCORCCC repre-
sents a framework for global cooperative efforts in the future. SIOP
and SJCRH formed a partnership aimed at disseminating the GCOR-
CCC widely and rapidly throughout the global network, leveraging
the strengths of both organizations. This platform shows that novel,
dynamic information resources can help provide guidance to frontline
providers across the globe, facilitating the rapid sharing and adoption
of new information in highly dynamic situations. The collaborations
built through this rapid multidisciplinary implementation and global
dissemination process provide a foundation upon which the global
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community can collectively build to ultimately improve outcomes for
all childrenwith cancer everywhere.
In memoriam: This manuscript is dedicated to Dr. Arturo Moreno,
past president of SLAOP/SIOP Latin America, a tireless advocate for
children with cancer inMexico, Latin America, and the world.
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